RBM18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.80486786311485E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63025148935958E-12 |
Normal-vs-Stage2 |
1.499880E-03 |
Normal-vs-Stage3 |
6.25319999999485E-05 |
Normal-vs-Stage4 |
2.280800E-01 |
Stage1-vs-Stage2 |
2.026400E-01 |
Stage1-vs-Stage3 |
1.839190E-01 |
Stage1-vs-Stage4 |
6.073600E-02 |
Stage2-vs-Stage3 |
9.078400E-01 |
Stage2-vs-Stage4 |
4.364800E-01 |
Stage3-vs-Stage4 |
3.402200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.73665592596262E-14 |
Normal-vs-AfricanAmerican |
6.19539997082086E-09 |
Normal-vs-Asian |
8.934300E-02 |
Caucasian-vs-AfricanAmerican |
7.974000E-01 |
Caucasian-vs-Asian |
9.068400E-01 |
AfricanAmerican-vs-Asian |
9.769600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.99760216648792E-15 |
Normal-vs-Female |
1.70878999999902E-05 |
Male-vs-Female |
1.962110E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.76159997489611E-09 |
Normal-vs-Extreme_Weight |
5.05151476204446E-14 |
Normal-vs-Obese |
1.9477199999951E-05 |
Normal-vs-Extreme_Obese |
1.268310E-02 |
Normal_Weight-vs-Extreme_Weight |
7.099800E-01 |
Normal_Weight-vs-Obese |
1.991560E-01 |
Normal_Weight-vs-Extreme_Obese |
9.697400E-01 |
Extreme_Weight-vs-Obese |
6.142500E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.018400E-01 |
Obese-vs-Extreme_Obese |
5.028800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.805840E-02 |
Normal-vs-Age(41-60Yrs) |
3.52699980332716E-10 |
Normal-vs-Age(61-80Yrs) |
2.89768209427166E-14 |
Normal-vs-Age(81-100Yrs) |
6.82199963186747E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.721000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.208400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.563400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.994000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.335700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.214000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62880819942757E-12 |
Normal-VS-Type2 PRCC |
1.05449999843188E-08 |
Normal-VS-KIRP CIMP |
8.879200E-01 |
Normal-VS-Unclassified PRCC |
1.98210000001975E-06 |
Type1 PRCC-VS-Type2 PRCC |
2.347400E-01 |
Type1 PRCC-VS-KIRP CIMP |
3.958400E-02 |
Type1 PRCC-VS-Unclassified PRCC |
6.230600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.824100E-03 |
Type2 PRCC-VS-Unclassified PRCC |
7.164600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.151890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.04749542373384E-11 |
Normal-vs-N1 |
7.459500E-02 |
Normal-vs-N2 |
2.425000E-01 |
N0-vs-N1 |
3.093800E-02 |
N0-vs-N2 |
5.324600E-01 |
N1-vs-N2 |
5.993400E-01 |
|
|